Ge Long Hui A P P·2026-01-22 12:44Core Viewpoint - *ST Bio (000504.SZ) is expected to achieve a net profit attributable to shareholders of 28.5 million to 32.5 million yuan in 2025, marking a turnaround from loss to profit compared to the previous year [1] Group 1: Financial Performance - The company anticipates a net profit of 8.5 million to 12.5 million yuan after deducting non-recurring gains and losses, also indicating a turnaround from loss to profit year-on-year [1] - Projected operating revenue is between 385 million to 425 million yuan [1] Group 2: Business Development - During the reporting period, the company acquired and took control of Loudi Jinhong New Materials Co., Ltd., which significantly enhanced its revenue from the recycling of resources such as waste power batteries and scrap steel [1] - The company has actively expanded sales of related derivative products in its main business, including beauty products and health supplements related to the biopharmaceutical sector, contributing to revenue and profit growth [1] Group 3: Cost Management - The company improved its profitability through measures such as organizational restructuring, personnel optimization, and cost control [1] - Government subsidies received during the reporting period increased compared to the previous year [1]